Design, synthesis and biological activity of rigid cannabinoid CB1 receptor antagonists

被引：59

作者：

Stoit, AR ^{[1
]}

Lange, JHM ^{[1
]}

den Hartog, AP ^{[1
]}

Ronken, E ^{[1
]}

Tipker, K ^{[1
]}

van Stuivenberg, HH ^{[1
]}

Dijksman, JAR ^{[1
]}

Wals, HC ^{[1
]}

Kruse, CG ^{[1
]}

机构：

[1] Solvay Pharmaceut Res Labs, NL-1380 DA Weesp, Netherlands

来源：

CHEMICAL & PHARMACEUTICAL BULLETIN | 2002年 / 50卷 / 08期

关键词：

benzocycloheptapyrazole; CB1 receptor antagonist; molecular modeling; regiochemistry;

D O I：

10.1248/cpb.50.1109

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The design, synthesis and biological activities of potent pyrazole-based tricyclic CB1 receptor antagonists (2) are described. The key synthetic step involves the ring closure of the lithiated alpha,gamma-keto ester adduct (4). The optimal nitroderivative (28) in this series exhibits a high CB1 receptor affinity (pK(i)=7.2) as well as very potent antagonistic activity (pA(2)=8.8) in vitro. The regioselectivity of the pyrazole ring closure is shown to depend strongly on the aromatic substitution pattern of the applied arylhydrazine.

引用

页码：1109 / 1113

页数：5

共 50 条

[31] Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders
Beardsley, Patrick M.
Thomas, Brian F.
Mcmahon, Lance R.
INTERNATIONAL REVIEW OF PSYCHIATRY, 2009, 21 (02) : 134 - 142
[32] A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders
Witkin, JM
Tzavara, ET
Davis, RJ
Li, X
Nomikos, GG
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (12) : 609 - 617
[33] CB1 cannabinoid receptor antagonists: a novel approach for the treatment of liver fibrosis
Teixeira-Clerc, Fatima
Julien, Boris
Grenard, Pascale
Van Nhieu, Jeanne Tran
Deveaux, Vanessa
Li, Liying
Serriere-Lanneau, Valerie
Ledent, Catherine
Mallat, Ariane
Lotersztajn, Sophie
M S-MEDECINE SCIENCES, 2006, 22 (8-9): : 683 - 685
[34] Cannabinoid CB1 Receptor Antagonists (vol 70, pg 525, 2009)
Thomas, Brian F.
Beardsley, Patrick M.
Seltzman, Herbert H.
DRUG DEVELOPMENT RESEARCH, 2010, 71 (02) : 159 - 159
[35] Identification of novel antagonists of CB1 cannabinoid receptors
Burstein, Ethan S.
Ott, Thomas R.
Bulow, Anne
Ek, Fredrick
Ma, Jian-Nong
Pettersson, Hanna
Jensen, Jacob
Ottesen, Lars
Owens, Michelle L.
Clemons, Bryan
Bertozzi, Fabio
Johnson, Robert W.
Sweetnam, Timothy
Currier, Erika
Del Tredici, Andria L.
Schiffer, Hans H.
Piu, Fabrice
McFarland, Krista
Tabatabaei, Ali
Gardelli, Luis R.
Olsson, Roger
Bonhaus, Doug
FASEB JOURNAL, 2008, 22
[36] CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a
Niehaus, Jason L.
Liu, Yunguang
Wallis, Kathleen T.
Egertova, Michaela
Bhartur, Sheela G.
Mukhopadhyay, Somnath
Shi, Shanping
He, Hengjun
Selley, Dana E.
Howlett, Allyn C.
Elphick, Maurice R.
Lewis, Deborah L.
MOLECULAR PHARMACOLOGY, 2007, 72 (06) : 1557 - 1566
[37] Synthesis and SAR of 1,4,5,6-tetrahydropyridazines as potent cannabinoid CB1 receptor antagonists
Lange, Jos H. M.
den Hartog, Arnold P.
van der Neut, Martina A. W.
van Vliet, Bernard J.
Kruse, Chris G.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (19) : 5675 - 5678
[38] Design, synthesis and biological evaluation of CB1 cannabinoid receptor ligands derived from the 1,5-diarylpyrazole scaffold
Tu, GuoGang
Xiong, Fang
Huang, HuiMing
Kuang, BinHai
Li, ShaoHua
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2011, 26 (02) : 222 - 230
[39] Occupancy of brain cannabinoid CB1 receptors and biological activity.
Gatley, SJ
Gifford, AN
Pyatt, BE
Liu, Q
Makriyannis, A
Volkow, ND
JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 108P - 108P
[40] Voltage dependence of the cannabinoid CB1 receptor
Goldberger, Esty
Tauber, Merav
Ben-Chaim, Yair
FRONTIERS IN PHARMACOLOGY, 2022, 13

← 1 2 3 4 5 →